Curr Pharm Des 20(7):11211125 Seiwerth S, Rucman R, Turkovic B, Sever M, Klicek R, Radic B, et al (2018) BPC 157 and standard angiogenic growth factors
Compound 13 significantly inhibited the signal transduction pathway mediated by NF-B in LPS-stimulated murine RAW264.7 macrophages, reducing the expression of pro-inflammatory TNF-, COX-2, IL-1, and IL-6, while also decreasing ROS and NO generation
No complications from checkout to delivery
121.5
An FDA-approved drug is reviewed as a specific product with defined manufacturing controls, labeling, and evidence for approved uses
Despite the warning label, individuals continue to use them and the individual does not know what they are getting all the time. There is some research on the following peptide injections: Body Protection Compound-157 (BPC-157) Initial and pre-clinical-trial research suggest BPC-157 may promote musculoskeletal healing, which could explain its popularity among athletes (although it is banned in professional sports)